B3GNT5 Antikörper
Kurzübersicht für B3GNT5 Antikörper (ABIN5703562)
Target
Alle B3GNT5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Immunogen
- UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
mouse lung tissue were subjected to SDS PAGE followed by western blot with FNab00769(B3GNT5 antibody) at dilution of 1:500
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Haltbarkeit
- 12 months
-
-
- B3GNT5 (UDP-GlcNAc:betaGal beta-1,3-N-Acetylglucosaminyltransferase 5 (B3GNT5))
-
Andere Bezeichnung
- B3GNT5
-
Hintergrund
- Synonyms: Background:Beta-1,3-N-acetylglucosaminyltransferase that plays a key role in the synthesis of lacto-or neolacto-series carbohydrate chains on glycolipids, notably by participating in biosynthesis of HNK-1 and Lewis X carbohydrate structures. Has strong activity toward lactosylceramide(LacCer) and neolactotetraosylceramide(nLc(4)Cer, paragloboside), resulting in the synthesis of Lc(3)Cer and neolactopentaosylceramide(nLc(5)Cer), respectively. Probably plays a central role in regulating neolacto-series glycolipid synthesis during embryonic development.
-
Molekulargewicht
- 44 kDa
-
Gen-ID
- 84002
-
UniProt
- Q9BYG0
Target
-